[1] |
XU Jialan, YAN Hong, WEN Jun, ZHOU Zitong, WANG Siyu.
Prevalence of Potentially Inappropriate Medication in Older Adults with Cancer: a Meta-analysis
[J]. Chinese General Practice, 2025, 28(30): 3815-3822.
|
[2] |
LYU Juan, LI Yuchuan, CAI Siyu, WANG Chen.
Reasons for Seeking Medical Treatment in Endocrinology Department and the Need for Non-medical Intervention in Children with Normal Height: a Qualitative Study
[J]. Chinese General Practice, 2025, 28(30): 3766-3772.
|
[3] |
ZHANG Tianyu, YU Haibo, CHEN Fei, LI Xin, ZHANG Jiajia, ZHAN Xiaokai, SHEN Man, TANG Ran, FAN Sibin, ZHAO Fengyi, HUANG Zhongxia.
Meta-analysis of the Efficacy and Safety of Systemic Treatment for POEMS Syndrome
[J]. Chinese General Practice, 2025, 28(27): 3447-3455.
|
[4] |
QUAN Jialin, ZHU Lin, SU Yu, CHEN Zekai, CHEN Ziqi, ZHANG Zhuofan.
Research on the Improvement Effect of Exercise Modes on the Executive Function of Overweight or Obese Children or Adolescents: a Network Meta-analysis
[J]. Chinese General Practice, 2025, 28(27): 3422-3431.
|
[5] |
LUO Xinyu, LIU Jin, CHEN Hailong.
Trend Analysis of the Changing Disease Burden of Pancreatitis in China and Worldwide from 1990 to 2021 and Prediction for 2022 to 2031
[J]. Chinese General Practice, 2025, 28(26): 3321-3327.
|
[6] |
YU Zizi, LIU Duli, LI Ximin, RUAN Chunyi, YIN Xiangyang, CAI Le.
Analysis of the Prevalence and Self-management of Hypertension and Its Influencing Factors in Rural
[J]. Chinese General Practice, 2025, 28(25): 3137-3143.
|
[7] |
JIANG Shihua, ZHU Zheng, REN Yingying, ZHU Yaolei, WANG Yue, GAO Xibin.
Meta Analysis of the Prevalence and Risk Factors of Myopia in Chinese Children and Adolescents
[J]. Chinese General Practice, 2025, 28(24): 3043-3052.
|
[8] |
LI Hao, LI Jiangtao, LIU Dan, WANG Jianjun.
Efficacy and Safety of Belimumab, Anifrolumab, and Telitacicept on the Treatment of Systemic Lupus Erythematosus: a Network Meta-analysis
[J]. Chinese General Practice, 2025, 28(23): 2924-2933.
|
[9] |
WANG Xiaolin, LI Qiuyue, ZHOU Yanjun, ZHANG Jinhui, LIANG Tao.
Incidence and Risk of Cardiovascular Toxicity with Fruquintinib in Metastatic Colorectal Cancer: a Meta-analysis
[J]. Chinese General Practice, 2025, 28(23): 2934-2940.
|
[10] |
MA Panpan, WANG Sijing, YOU Na, DING Dafa, LU Yibing.
Efficacy and Safety of Danuglipron and Orforglipron in the Treatment of Type 2 Diabetes Mellitus: a Meta-analysis
[J]. Chinese General Practice, 2025, 28(21): 2679-2685.
|
[11] |
HU Wanqin, YU Shenyan, CAO Xuehua, XIANG Feng, JIA Yu.
Factors Associated with Precocious Puberty in Chinese Children: a Meta-analysis
[J]. Chinese General Practice, 2025, 28(21): 2661-2671.
|
[12] |
ADILI Tuersun, CHENG Gang.
Meta-analysis of the Efficacy and Safety of Finerenone in the Treatment of Type 2 Diabetic Nephropathy
[J]. Chinese General Practice, 2025, 28(21): 2686-2691.
|
[13] |
GUO Shengteng, ZHANG Fenfen, WAN Di, YU Dongmei, WANG Qinghua.
Risk Factors for Severe Acute Pancreatitis Complicated with Acute Lung Injury: a Meta-analysis
[J]. Chinese General Practice, 2025, 28(20): 2546-2554.
|
[14] |
GUO Yi, HAN Xuanye, LIU Zhaojun, JIANG Yaoyao, FU Yang, SHI Lei, ZHAO Shihong.
Construction of a Medical Transition Intervention Model for Multiple Chronic Diseases in Children Based on the E-Coach Management Model
[J]. Chinese General Practice, 2025, 28(20): 2530-2537.
|
[15] |
GUO Xiangyun, ZHANG Yili, LI Ting, FENG Tianxiao, LI Linghui, SUN Kai, WANG Xu, QIN Xiaokuan, TIAN Jinzhou, ZHU Liguo, WEI Xu.
Analysis of Prevalence Trends and Factors Influencing Key Bone Health Conditions
[J]. Chinese General Practice, 2025, 28(19): 2346-2353.
|